These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19169031)

  • 1. Assessment of viable tumour tissue attached to needle applicators after local ablation of liver tumours.
    Snoeren N; Jansen MC; Rijken AM; van Hillegersberg R; Slooter G; Klaase J; van den Tol PM; van der Linden E; Ten Kate FJ; van Gulik TM
    Dig Surg; 2009; 26(1):56-62. PubMed ID: 19169031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viable tumor tissue adherent to needle applicators after local ablation: a risk factor for local tumor progression.
    Snoeren N; Huiskens J; Rijken AM; van Hillegersberg R; van Erkel AR; Slooter GD; Klaase JM; van den Tol PM; Ten Kate FJ; Jansen MC; van Gulik TM
    Ann Surg Oncol; 2011 Dec; 18(13):3702-10. PubMed ID: 21590455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consequences of needle tract seeding of hepatocellular cancer after liver transplant.
    Lopez KT; Kuwada SK; Wong LL
    Clin Transplant; 2013; 27(4):E400-6. PubMed ID: 23837571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Assessment of viable tumour tissue attached to needle applicators after local ablation of liver tumours.
    Sofocleous CT; Petre N; Manova-Todorova K; Petrovic L; Gonen M
    Dig Surg; 2009; 26(5):434-5; author reply 435. PubMed ID: 19923834
    [No Abstract]   [Full Text] [Related]  

  • 5. Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: a prospective study.
    Latteri F; Sandonato L; Di Marco V; Parisi P; Cabibbo G; Lombardo G; Galia M; Midiri M; Latteri MA; Craxì A
    Dig Liver Dis; 2008 Aug; 40(8):684-9. PubMed ID: 18294940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
    Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
    Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Local recurrence following hepatic radiofrequency ablation: diagnosis and treatment].
    Eisele RM; Schumacher G; Neuhaus P
    Strahlenther Onkol; 2008 Nov; 184(11):598-604. PubMed ID: 19016019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of tumour progression in early-stage hepatocellular carcinoma after radiofrequency ablation.
    Fernandes ML; Lin CC; Lin CJ; Chen WT; Lin SM
    Br J Surg; 2009 Jul; 96(7):756-62. PubMed ID: 19526609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous biopsy of operable liver lesions: is it necessary or advisable?
    Jourdan JL; Stubbs RS
    N Z Med J; 1996 Dec; 109(1035):469-70. PubMed ID: 9006629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bimodal electric tissue ablation-long term studies of morbidity and pathological change.
    Dobbins C; Brennan C; Wemyss-Holden S; Cockburn J; Maddern G
    J Surg Res; 2008 Aug; 148(2):251-9. PubMed ID: 18395751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency ablation combined with transarterial chemoembolization for unresectable primary liver cancer.
    Wang YH; Liu JF; Li F; Li A; Liu Q; Liu DB; Liu DG; Wang YJ
    Chin Med J (Engl); 2009 Apr; 122(8):889-94. PubMed ID: 19493409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of percutaneous therapy.
    Gillams AR
    Cancer Imaging; 2005 Sep; 5(1):110-3. PubMed ID: 16305947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update.
    Mulier S; Ruers T; Jamart J; Michel L; Marchal G; Ni Y
    Dig Surg; 2008; 25(6):445-60. PubMed ID: 19212117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
    J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipiodol and dye at the site of ablation decreases during RFA.
    Hirakawa M; Ikeda K; Kawamura Y; Kobayashi M; Hosaka T; Yatsuji H; Sezaki H; Akuta N; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
    Intervirology; 2008; 51(5):362-8. PubMed ID: 19127079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour seeding following percutaneous needle biopsy of hepatocellular carcinoma.
    Qua CS; Wong CH; Goh KL
    Singapore Med J; 2008 Jan; 49(1):e8-11. PubMed ID: 18204759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CT-guided radiofrequency ablation of liver metastases from colorectal cancer].
    Mahnken AH; Bruners P; Tacke JA; Günther RW
    Dtsch Med Wochenschr; 2009 May; 134(19):976-80. PubMed ID: 19401962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Needle biopsy of breast cancer. Appearance of tumour cells along the needle track.
    Grabau DA; Andersen JA; Graversen HP; Dyreborg U
    Eur J Surg Oncol; 1993 Apr; 19(2):192-4. PubMed ID: 8491325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors.
    Yin XY; Xie XY; Lu MD; Xu HX; Xu ZF; Kuang M; Liu GJ; Liang JY; Lau WY
    Cancer; 2009 May; 115(9):1914-23. PubMed ID: 19241423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study for a new bipolar radiofrequency ablation/aspirator device in the management of primary and secondary liver cancers.
    Zacharoulis D; Khorsandi SE; Vavra P; Dostalik J; Navarra G; Nicholls JP; Jiao LR; Habib NA
    Liver Int; 2009 Jul; 29(6):824-30. PubMed ID: 19638109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.